Israel Vaccine Market (2025-2031) | Trends, Supply, Outlook, Strategy, Growth, Competition, Segments, Value, Revenue, Opportunities, Pricing Analysis, Demand, Restraints, Share, Challenges, Companies, Strategic Insights, Consumer Insights, Analysis, Segmentation, Competitive, Forecast, Investment Trends, Size, Industry, Drivers

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Vaccine Market Revenues & Volume, 2021 & 2031F

3.3 Israel Vaccine Market - Industry Life Cycle

3.4 Israel Vaccine Market - Porter's Five Forces

3.5 Israel Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Israel Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.7 Israel Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F

3.8 Israel Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 Israel Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the importance of vaccination in preventing diseases

4.2.2 Government initiatives to promote vaccination programs

4.2.3 Growing investments in research and development for new vaccines

4.3 Market Restraints

4.3.1 Vaccine hesitancy among certain population groups

4.3.2 Stringent regulatory requirements for vaccine approval

4.3.3 Limited access to vaccines in remote or underdeveloped areas

6.1 Israel Vaccine Market, By Type

6.1.1 Overview and Analysis

6.1.2 Israel Vaccine Market Revenues & Volume, By Type, 2021 - 2031F

6.1.3 Israel Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F

6.1.4 Israel Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F

6.1.5 Israel Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F

6.2 Israel Vaccine Market, By Disease Indication

6.2.1 Overview and Analysis

6.2.2 Israel Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F

6.2.3 Israel Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F

6.2.4 Israel Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F

6.3 Israel Vaccine Market, By Age Group

6.3.1 Overview and Analysis

6.3.2 Israel Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F

6.3.3 Israel Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F

6.3.4 Israel Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F

6.4 Israel Vaccine Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 Israel Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F

6.4.3 Israel Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F

6.4.4 Israel Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F

6.5 Israel Vaccine Market, By Technology

6.5.1 Overview and Analysis

6.5.2 Israel Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F

6.5.3 Israel Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F

6.5.4 Israel Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F

7.1 Israel Vaccine Market Export to Major Countries

7.2 Israel Vaccine Market Imports from Major Countries

8.1 Immunization coverage rate

8.2 Number of vaccines included in the national immunization schedule

8.3 Vaccine wastage rate

8.4 Vaccine distribution efficiency

8.5 Adverse events following immunization rate

9.1 Israel Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Israel Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

9.3 Israel Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F

9.4 Israel Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 Israel Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F

10.1 Israel Vaccine Market Revenue Share, By Companies, 2024

10.2 Israel Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters